Promedior, Inc.
Promedior Closes $12 Million Series C Financing
Published in Law and Health Weekly, April 3rd, 2010
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat inflammatory and fibrotic diseases, announced that it has raised $12 million in a Series C financing round. Forbion Capital Partners led the round, with participation from existing investors Morgenthaler Ventures, HealthCare Ventures, Polaris Venture Partners, and Easton Capital. The Series C financing brings the total capital raised by Promedior over the past year to $27 million.
Proceeds from the Series C financing will enable Promedior to accelerate the development of its pipeline and expand the clinical development program for its lead drug candidate, PRM-151, into Phase 2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- (Cover the Uninsured, Facts and
National Medical Association - Will Status Quo Persist in Health Care? - 1105 Government Information Group
GovSec Announces Homeland Security Finance Forum Speakers - AARP Idaho
Gov. Signs Law Putting Politics Before Patients - AARP Idaho
Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights - Acacia Research Corporation
Acacia Subsidiary Licenses Medical Monitoring Technology to Draeger Medical - Acacia Research Corporation
Acacia Subsidiary Licenses Medical Picture Archiving and Communication System PACS Technology to Carestream Health - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
